Pour une prise en charge préventive de la maladie d’Alzheimer

Autor: B, Dubois, S, Bombois, N, Villain, M, Teichmann, S, Epelbaum, R, Migliaccio, R, Genthon, B, Verrat, C, Lesoil, M, Levy, I, Le Ber, R, Levy

Publikováno v: Bulletin de l'Académie Nationale de Médecine
Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2020, 204 (6), pp.583-588. ⟨10.1016/j.banm.2020.04.012⟩

International audience; Dementias, and Alzheimer's disease (AD) in particular, will increasingly become a public health issue. However, three major data may change the severity of these pathologies: in young adults, simple measures of healthy lifesty

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4361d7319e021311a04d10a7b8286897
https://hal.sorbonne-universite.fr/hal-03017146/document

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kinetics, safety, and efficacy of ramipril after long-term administration in hemodialyzed patients

Autor: R. Genthon, B. Legallicier, Michel Godin, N. Carcone, N. De La Rey, D. Dubois, J. Vauquier, J. C. Baguet, H. G. Luus, Jean-Paul Fillastre

Publikováno v: Journal of cardiovascular pharmacology. 27(2)

We studied the efficacy and safety of ramipril and the kinetics of its active moiety ramiprilat in 12 hypertensive patients receiving regular hemodialysis, after a single dose and after long-term (28 days) administration. Patients received 2.5 mg ram

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59210703eb85ecf943b73a05cdefc5e3
https://pubmed.ncbi.nlm.nih.gov/8720427

Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension. ATHES Study Group

Autor: R, Genthon

Publikováno v: International journal of clinical pharmacology research. 14(1)

In a double-blind, parallel-group multicentre study, the efficacy and safety of a fixed low-dose combination of ramipril 2.5 mg and hydrochlorothiazide (HCT) 12.5 mg was compared with each of the component drugs when given as monotherapy. After a fou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3d4422906266ff571fe7880b75579f2e
https://pubmed.ncbi.nlm.nih.gov/7927956

[Gerstmann-Sträussler-Scheinker disease. Pathologal and genetic study]

Autor: R, Genthon, F, Gray, J, Salama, C, Duyckaerts, C, Belin, J M, Brucher, H, Baron, P, Delaporte

Publikováno v: Revue neurologique. 148(5)

Gerstmann-Sträussler-Scheinker's disease is a familial spongiform encephalopathy whose pathological hallmark is the existence--especially in the cerebellum--of numerous amyloid plaques. We report here the third clinicopathological case in a French f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::503bd22153da82987e7b21ed0bba9106
https://pubmed.ncbi.nlm.nih.gov/1448647